Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00240747 |
|
Recruitment Status :
Terminated
First Posted : October 18, 2005
Last Update Posted : May 25, 2012
|
Sponsor:
Pfizer
Collaborator:
Aventis Pharmaceuticals
Information provided by:
Pfizer
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Primary Completion Date : | No date given |
| Study Completion Date : | January 2005 |